bicalutamide has been researched along with mecamylamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Cao, Q; Gong, Y; Gu, J; He, Z; Nie, H; Zhu, L | 1 |
1 review(s) available for bicalutamide and mecamylamine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for bicalutamide and mecamylamine
| Article | Year |
|---|---|
Acetylcholine acts on androgen receptor to promote the migration and invasion but inhibit the apoptosis of human hepatocarcinoma.
Topics: Acetylcholine; Androgen Antagonists; Androgens; Anilides; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Female; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Male; Mecamylamine; Metribolone; Neoplasm Invasiveness; Nitriles; Phosphorylation; Proto-Oncogene Proteins c-akt; Receptors, Androgen; Receptors, Cholinergic; RNA, Small Interfering; Signal Transduction; STAT3 Transcription Factor; Tosyl Compounds; Transcription, Genetic; Up-Regulation | 2013 |